Lysosomal Expression Profile in Plasma Associates with Disease Severity in Parkinson's Disease.
These findings support the use of pathway-specific biomarkers for improving PD diagnostics and monitoring disease progression and support the use of pathway-specific biomarkers for improving PD diagnostics and monitoring disease progression.